PRIME-ROSE
1 abstract
Abstract
Single point of entry to the European precision cancer medicine trial network PRIME-ROSE.Org: Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and University of Oslo, Oslo, Norway, National Cancer Institute, Vilnius, Lithuania, The Swedish Institute for Health Economics, Lund, Sweden, Oslo University Hospital, Division of Cancer Medicine, Oslo, Norway, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland,